Acorn Biolabs, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Acorn Biolabs, Inc. - overview
Established
2017
Location
Toronto, ON, Canada
Primary Industry
Biotechnology
About
Based in Ontario, Canada, and founded in 2017 by Chief Executive Officer Drew Taylor, Chief Information Officer Steven ten Holder, and co-founder Patrick Pumputis, Acorn Biolabs, Inc. operates healthtech based company providing take-home human cell cryopreservation service such as tissue engineering, and organ regeneration. In January 2024, Acorn Biolabs, Inc. raised CAD 11 million in series A funding led by new investor Merz Aesthetics, with participation from other new investors TELUS Ventures, MDE Investments, The Leslie Group, and Lee Li Holdings.
Individual investors also participated in the round. Acorn Biolabs, Inc. develops customized regenerative medicines for patients by accessing the cells, analysis and cryopreservation, and cell based topical treatment. The company offers preserved stem cells for future regenerative treatments, including both therapeutic and aesthetic applications.
In addition, the firm focuses on anti-aging through treating the cells in human body, which have potential to rejuvenate skin, replenish hair, and other disease. The company plans to use the funding from January 2024 to increase the size of our business activities in the United States and Canada and to conduct further research and development on regenerative aesthetic applications.
Current Investors
Real Ventures, Epic Capital Management, Pool Global Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Aesthetic Medicine, Alternative Medicine, Healthcare IT, Pharmaceutical Research & Development
Website
www.acorn.me
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.